Souders Financial Advisors
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1811240
CINCINNATI, OH
Position in VRTX
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,227,419
+$112,409 QoQ
Shares Held
2,471
-1.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#797
of 1,735 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Souders Financial Advisors holds $1,759,941 across 2 Biotechnology names. VRTX ranks #1 (69.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
2,471 | $1,227,419 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,769 | $532,522 |
All Filings in VRTX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,227,419 | 2,471 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,115,010 | 2,497 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $909,440 | 2,006 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $690,852 | 1,764 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $582,766 | 1,309 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $526,999 | 1,087 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $461,896 | 1,147 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $681,807 | 1,466 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $673,081 | 1,436 | Shares | Sole | 2024-08-28 | |
| 2024-03-31 | $584,795 | 1,399 | Shares | Sole | 2024-05-08 | |
| No filing history on record for this holder in this stock. | ||||||